Načítá se...
Novel Antimicrobials for the Treatment of Clostridium difficile Infection
The current picture of Clostridium difficile infection (CDI) is alarming with a mortality rate ranging between 3% and 15% and a CDI recurrence rate ranging from 12% to 40%. Despite the great efforts made over the past 10 years to face the CDI burden, there are still gray areas in our knowledge on CD...
Uloženo v:
| Vydáno v: | Front Med (Lausanne) |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5911476/ https://ncbi.nlm.nih.gov/pubmed/29713630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2018.00096 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|